WINDOW INTO HTA: Assessing The Reimbursement Climate For Your Product
This article was originally published in Clinica
Executive Summary
In the final part of Clinica’s series on heath technology assessment in the EU, Mark Charny looks beyond HTA and discusses what factors to consider when gauging the reimbursement potential of your product from a payer’s perspective